---
title: Nutritional Intervention For The Treatment Of Uncomplicated SAM
nct_id: NCT05390437
overall_status: COMPLETED
phase: NA
sponsor: Sanaullah Iqbal
study_type: INTERVENTIONAL
primary_condition: Child Nutrition Disorders
countries: Pakistan
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05390437.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05390437"
ct_last_update_post_date: 2022-05-25
last_seen_at: "2026-05-12T06:25:52.614Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Nutritional Intervention For The Treatment Of Uncomplicated SAM

**Official Title:** Nutritional Intervention For The Treatment Of Uncomplicated Severe Acute Malnutrition in South Punjab Pakistan

**NCT ID:** [NCT05390437](https://clinicaltrials.gov/study/NCT05390437)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 200
- **Lead Sponsor:** Sanaullah Iqbal
- **Collaborators:** University of the Punjab
- **Conditions:** Child Nutrition Disorders
- **Start Date:** 2020-01-04
- **Completion Date:** 2022-03-15
- **CT.gov Last Update:** 2022-05-25

## Brief Summary

nutritional intervention with ready to use therapeutic food (plumpy nut. by Unicef) and Prebiotics supplimentation ( Galactooligosaccarides). will be given to uncomplicated severe acute malnourished children of 06 months to 59 months of age in southern Punjab Pakistan.one group will be given Ready to use therapeutic food and placebo the other group will be given Prebiotics supplementation (Galacto oligosaccharides) with RUTF ( Ready to use therapeutic Foods).for 60 days primary out will be Mid Upper Arm Circumference \>11.5 centimetre

## Detailed Description

it will be a double blind Randomised Controlled trial in Out Therapeutic Program centres of Teaching Hospital of Dera Ghazi Khan Pakistan children age of 06 months to 59 months of age from the community will be screened out at health centres . Uncomplicated SAM children will be enrolled for study Before intervention there blood sample and stool sample will be sent to the labs for complete blood examination and complete stool examination.

controlled groups will be given Ready To use Therapeutic Food and Placebo (starch) 4 grams per day for 60 days Intervention group will be given Ready to use Therapeutic Food and Prebiotic ( Galactoligosaccharides 4 gram per day for 60 days

## Eligibility

- **Minimum age:** 6 Months
- **Maximum age:** 59 Months
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Uncomplicated Severely Acute Malnourished Children

Exclusion Criteria:

* Severely Acute Malnourished children with complication
```

## Arms

- **control group** (PLACEBO_COMPARATOR) — starch (placebo) 4 grams per day for 60 days
- **Interventional group** (EXPERIMENTAL) — Prebiotics (GOS) Galactooligosaccharides 4 gram per day for 60 days

## Interventions

- **Nutritional intervention with Ready to use theraputic food (RUTF) and prebiotic GOS (galacto oligosaccharides) in combination** (DIETARY_SUPPLEMENT) — 4gm of prebiotic GOS ( Galactooligosaccharides) and Ready to use theraputic food (RUTF) as per WHO standard on daily basis for 60 Days
- **Ready to use theraputic food (RUTF) and Starch (placebo)** (DIETARY_SUPPLEMENT) — Ready to use therapeutic food (RUTF) as per WHO standard and (Starch Placebo) soluble in water and mix in food on daily basis for 60 Days

## Primary Outcomes

- **Nutritional cure** _(time frame: 60 Days)_ — Mid Upper Arm Circumference of left arm is measured at the mid point between the tips of shoulder and elbow.It is measured by MUAC tape . More than 11.5 centimetre according to WHO criteria will be primary outcome

## Secondary Outcomes

- **Weight gain in kilograms** _(time frame: 60 Days)_

## Locations (1)

- DG Khan, Dera Ghazi Khan, Punjab Province, Pakistan

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.dg khan|dera ghazi khan|punjab province|pakistan` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05390437.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05390437*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*